Shenzhen Salubris Pharmaceuticals Co Ltd Tangible Net Worth Ratio
Shenzhen Salubris Pharmaceuticals Co Ltd tangible net worth ratio. Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a Tangible Net Worth Ratio of 62.6% as of September 2025. This metric is calculated by deducting intangible assets (CN¥3.34 Billion) from net assets (CN¥8.93 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 002294 net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)
Tangible net worth ratio of Shenzhen Salubris Pharmaceuticals Co Ltd from 2006 to 2024. This chart shows how Shenzhen Salubris Pharmaceuticals Co Ltd's Tangible Net Worth Ratio has changed across 19 annual periods from 2006 to 2024. As of September 2025, the ratio stands at 62.6%, reflecting net assets of CN¥8.93 Billion with intangible assets of CN¥3.34 Billion CNY. Check Shenzhen Salubris Pharmaceuticals Co Ltd (002294) strategic investment index to assess the company's strategic physical and investment asset allocation.
Shenzhen Salubris Pharmaceuticals Co Ltd Tangible Net Worth Ratio by Year (2006–2024)
Shenzhen Salubris Pharmaceuticals Co Ltd tangible net worth ratio by year from 2006 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Shenzhen Salubris Pharmaceuticals Co Ltd from 2006 to 2024, covering 19 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 002294 stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 67.8% | CN¥8.75 Billion | CN¥2.81 Billion | CN¥10.47 Billion | ▲ +0.3 pp |
| 2023 | 67.5% | CN¥8.06 Billion | CN¥2.62 Billion | CN¥9.40 Billion | ▼ -5.1 pp |
| 2022 | 72.6% | CN¥7.98 Billion | CN¥2.18 Billion | CN¥9.76 Billion | ▼ -2.4 pp |
| 2021 | 75.0% | CN¥8.05 Billion | CN¥2.01 Billion | CN¥9.24 Billion | ▲ +10.4 pp |
| 2020 | 64.6% | CN¥5.59 Billion | CN¥1.98 Billion | CN¥6.92 Billion | ▼ -9.4 pp |
| 2019 | 74.0% | CN¥6.67 Billion | CN¥1.73 Billion | CN¥7.73 Billion | ▲ +0.6 pp |
| 2018 | 73.3% | CN¥6.87 Billion | CN¥1.83 Billion | CN¥7.90 Billion | ▼ -4.7 pp |
| 2017 | 78.0% | CN¥6.16 Billion | CN¥1.36 Billion | CN¥6.86 Billion | ▲ +1.0 pp |
| 2016 | 77.0% | CN¥5.46 Billion | CN¥1.26 Billion | CN¥6.53 Billion | ▲ +2.6 pp |
| 2015 | 74.4% | CN¥4.70 Billion | CN¥1.20 Billion | CN¥5.39 Billion | ▲ +2.1 pp |
| 2014 | 72.3% | CN¥3.79 Billion | CN¥1.05 Billion | CN¥4.62 Billion | ▼ -11.1 pp |
| 2013 | 83.4% | CN¥3.13 Billion | CN¥519.32 Million | CN¥3.64 Billion | ▼ -10.1 pp |
| 2012 | 93.5% | CN¥2.61 Billion | CN¥169.26 Million | CN¥2.98 Billion | ▲ +0.8 pp |
| 2011 | 92.7% | CN¥2.13 Billion | CN¥155.80 Million | CN¥2.45 Billion | ▼ -4.6 pp |
| 2010 | 97.3% | CN¥1.87 Billion | CN¥49.70 Million | CN¥2.17 Billion | ▼ -2.0 pp |
| 2009 | 99.3% | CN¥1.62 Billion | CN¥11.46 Million | CN¥1.77 Billion | ▼ -0.7 pp |
| 2008 | 100.0% | CN¥262.90 Million | CN¥0.00 | CN¥408.60 Million | ▲ +0.3 pp |
| 2007 | 99.7% | CN¥145.96 Million | CN¥424.32K | CN¥255.94 Million | ▲ +0.5 pp |
| 2006 | 99.2% | CN¥106.48 Million | CN¥848.65K | CN¥158.66 Million | — |